Drug Use Investigation for HEPSERA (Adefovir) Tablet

GlaxoSmithKline (GSK)

Status: Completed

Conditions: Hepatitis B

Treatments: Drug: Adefovir tablets

Study type: Observational

Funder types: Industry

Identifiers

NCT01863589

112299

Details and patient eligibility

About

This post-marketing surveillance (PMS) is conducted to collect safety and efficacy data among subjects with chronic hepatitis B and hepatic cirrhosis B who is treated with adefovir tablets.

Enrollment: 436 patients

Sex: All

Volunteers: No Healthy Volunteers

Inclusion criteria

• Subjects with chronic hepatitis B or hepatic cirrhosis B
• Subjects treated with adefovir tablets

Exclusion criteria

• None

Trial design

436 participants in 1 patient group

Subjects prescribed adefovir tablets

Description:

Subjects with chronic hepatitis B or hepatic cirrhosis B to whom adefovir tablets are administered

Treatment:

Drug: Adefovir tablets